Skip to main content
. 2009 Nov 18;1(3):939–964. doi: 10.3390/v1030939

Figure 4.

Figure 4.

Antiviral peptides in clinical trials. (A) Zadaxin®, (B) IM862 and (C) SCV-07 are all compounds which have demonstrated promising results as immune modulators for treatment of patients with chronic hepatitis C virus infections.